Next Article in Journal
Modified Carnoy’s Versus Carnoy’s Solution in the Management of Odontogenic Keratocysts—A Single Center Experience
Next Article in Special Issue
Predicting Hepatotoxicity Associated with Low-Dose Methotrexate Using Machine Learning
Previous Article in Journal
Classification of Skin Cancer Using Novel Hyperspectral Imaging Engineering via YOLOv5
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Clinical, Translational and Experimental Pharmacotherapeutics Advances

1
Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China
2
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
3
Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China
4
Department of Thyroid and Breast Surgery, The Second Hospital of Anhui Medical University, Hefei 230601, China
5
AMITA Health Saint Joseph Hospital Chicago, Chicago, IL 60657, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(3), 1136; https://doi.org/10.3390/jcm12031136
Submission received: 28 January 2023 / Accepted: 31 January 2023 / Published: 1 February 2023
Pharmacotherapeutics is the prevention and treatment of ailments, whether disorders or diseases, with medication. In this Special Issue, we divide pharmacotherapeutics into three parts according to the stage of drug research and use, namely experimental pharmacotherapeutics, translational pharmacotherapeutics and clinical pharmacotherapeutics. The phrase experimental pharmacotherapeutics refers to the experimental and basic research for purpose of pharmacotherapeutics. Translational pharmacotherapeutics is a novel concept, which is devoted to translating novel theranostics from bench to bedside. Clinical pharmacotherapeutics refers to the rational use of drugs to diagnose, prevent and treat diseases in clinical practice. These three parts promote each other and develop together, fueling the progress of pharmacotherapeutics.
Pharmacotherapeutics is a field that has been absorbing novel technologies and lasting innovation, such as the design and discovery of new targets and new molecular entities, the establishment of new platforms for efficacy and safety evaluation, and new regimens of rational use in clinical practice. At the same time, this distinction also reflects the disciplinary characteristics of pharmacotherapeutics, a field which contains experimental, translational and clinical perspectives. There are many innovations and entry points, and their new advances need to be reported and displayed.
Clinical pharmacotherapeutics, serviced by experimental and translational pharmacotherapeutics, is the application of pharmacy knowledge together with information about the disease for management of health/ illness. Guiding clinical rational drug use and improving medication therapy management contribute to achieving the optimal level under the five rights of medication administration. Novel clinical pharmacotherapeutic applications also need to be explored and reported.
Devoting to rapidly reporting the latest advances, we also hope that this Special Issue can provide a comprehensive research frontier in this field and present an in-depth research progress of pharmacotherapeutics to readers.

Author Contributions

Z.H. wrote the manuscript; L.Y., Z.X. and C.S. checked and approved it carefully. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the 1.3.5 project for disciplines of excellence—clinical research incubation project, West China Hospital, Sichuan University, grant number 2021HXFH064.

Conflicts of Interest

The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

He, Z.; Yu, L.; Xu, Z.; Sun, C. Clinical, Translational and Experimental Pharmacotherapeutics Advances. J. Clin. Med. 2023, 12, 1136. https://doi.org/10.3390/jcm12031136

AMA Style

He Z, Yu L, Xu Z, Sun C. Clinical, Translational and Experimental Pharmacotherapeutics Advances. Journal of Clinical Medicine. 2023; 12(3):1136. https://doi.org/10.3390/jcm12031136

Chicago/Turabian Style

He, Zhiyao, Lei Yu, Zhijie Xu, and Chenyu Sun. 2023. "Clinical, Translational and Experimental Pharmacotherapeutics Advances" Journal of Clinical Medicine 12, no. 3: 1136. https://doi.org/10.3390/jcm12031136

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop